相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Dapagliflozin restores insulin and growth hormone secretion in obese mice
Zhengxiang Huang et al.
JOURNAL OF ENDOCRINOLOGY (2020)
Rapid Onset of Diabetic Ketoacidosis After SGLT2 Inhibition in a Patient With Unrecognized Acromegaly
Marino Quarella et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2017)
Ketosis and diabetic ketoacidosis in response to SGLT2 inhibitors: Basic mechanisms and therapeutic perspectives
Hongyu Qiu et al.
DIABETES-METABOLISM RESEARCH AND REVIEWS (2017)
Least-Squares Means: The R Package lsmeans
Russell V. Lenth
JOURNAL OF STATISTICAL SOFTWARE (2016)
Fitting Linear Mixed-Effects Models Using lme4
Douglas Bates et al.
JOURNAL OF STATISTICAL SOFTWARE (2015)
Inhibition of the glucose transporter SGLT2 with dapagliflozin in pancreatic alpha cells triggers glucagon secretion
Caroline Bonner et al.
NATURE MEDICINE (2015)
Metabolic response to sodium-glucose cotransporter 2 inhibition in type 2 diabetic patients
Ele Ferrannini et al.
JOURNAL OF CLINICAL INVESTIGATION (2014)
Safety, tolerability, pharmacokinetics and pharmacodynamics following 4 weeks' treatment with empagliflozin once daily in patients with type 2 diabetes
T. Heise et al.
DIABETES OBESITY & METABOLISM (2013)
Effects of Growth Hormone on Glucose, Lipid, and Protein Metabolism in Human Subjects
Niels Moller et al.
ENDOCRINE REVIEWS (2009)
Impact of Growth Hormone Receptor Blockade on Substrate Metabolism during Fasting in Healthy Subjects
Louise Moller et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2009)
Additive effects of cortisol and growth hormone on regional and systemic lipolysis in humans
CB Djurhuus et al.
AMERICAN JOURNAL OF PHYSIOLOGY-ENDOCRINOLOGY AND METABOLISM (2004)
Growth hormone receptor antagonists: Discovery, development, and use in patients with acromegaly
JJ Kopchick et al.
ENDOCRINE REVIEWS (2002)
分享论文
